I

Immuneering Corp
D

IMRX

1.81000
USD
-0.15
(-7.65%)
Market Open
Volume
1,415
EPS
0
Div Yield
0
P/E
-1
Market Cap
53,672,573
OverviewSignalsIdeasNews
Related Instruments
    A
    APTO
    -0.03680
    (-6.57%)
    0.52320 USD
    A
    ARCT
    -1.880
    (-8.01%)
    21.600 USD
    B
    BLCM
    -0.01620
    (-4.09%)
    0.36000 USD
    M
    MGTA
    0
    (0%)
    0.000000 USD
    P
    PTGX
    0.500
    (1.34%)
    37.930 USD
    R
    RIGL
    -0.552
    (-5.22%)
    10.030 USD
    T
    TCON
    0.00000
    (0.00%)
    1.45000 USD
    V
    VRNA
    -0.060
    (-0.26%)
    22.620 USD
    V
    VSTM
    -0.17000
    (-6.51%)
    2.44000 USD
    More
News

Title: Immuneering Corp

Sector: Healthcare
Industry: Biotechnology
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.